Hušáková, Markéta
Bay-Jensen, Anne-C.
Forejtová, Šárka
Zegzulková, Kateřina
Tomčík, Michal
Gregová, Monika
Bubová, Kristýna
Hořínková, Jana
Gatterová, Jindra
Pavelka, Karel
Siebuhr, Anne Sofie http://orcid.org/0000-0003-0802-8422
Article History
Received: 23 November 2018
Accepted: 12 July 2019
First Online: 2 August 2019
Change Date: 19 August 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing Interests
: A.S.S. and A.C.B.J. are full-time employees of Nordic Bioscience, which is a privately-owned SME that develops biomarkers of fibrosis. A.C.B.J. is also a stockholder of Nordic Bioscience. The authors have no other relevant affiliation or financial involvement with any organisation or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those previously disclosed. No writing assistance was used in the production of this manuscript. All authors of the Institute of Rheumatology (M.H., S.F., K.Z., M.T., M.G., K.B., J.H., J.G. and K.P.) declare no competing interest in this study. All authors declare no non-financial conflicts regarding to this study.